Evaluation of an aminobisphosphonate (alendronate) in the management of periodontal osseous defects
<b>Background and Objectives:</b> Alendronate, an aminobisphosphonate, is capable of inhibiting periodontitis associated osteoclastic activity and hence is effective in protecting the alveolar bone in periodontitis. In the present study, we explored the efficacy of local delivery of alen...
Saved in:
Main Authors: | Veena H (Author), Prasad Deepak (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2010-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biomaterials in periodontal osseous defects
by: Nand Lal, et al.
Published: (2012) -
Effect of in-situ application of simvastatin gel in surgical management of osseous defects in chronic periodontitis-A randomized clinical trial
by: Rajeev Ranjan, et al.
Published: (2017) -
Rubber dam as a barrier membrane in the treatment of periodontal osseous defect
by: Girish Nagarale, et al.
Published: (2012) -
Adjunctive use of autologous platelet concentrates in surgical management of periodontal osseous defects: A literature review
by: Shrushti Mahendra Sukalkar, et al.
Published: (2021) -
Bone Regeneration in Vertical Osseous Defect in Periodontitis Patients using Bovine Colostrum
by: P. L. Ravishankar, et al.
Published: (2022)